Volume 2 Issue 1 - 2016
Building Network
Susana Gorzalczany*
Department of Pharmacology, School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina
*Corresponding Author: Susana Gorzalczany, Department of Pharmacology, School of Pharmacy and Biochemistry, University of Buenos Aires, Junín 956 5 P, Ciudad Autónoma de Buenos Aires, Argentina.
Received: February 29, 2016; Published: July 06, 2016
Citation: Susana Gorzalczany. “Building Network”. EC Pharmacology and Toxicology 2.1 (2016): 55-56.
Drug discovery is a long and expensive process. During the first half of the 20th century drug research was shaped and enriched by several new technologies, all of which left their impression on drug discovery and on therapy.
Drug discovery represents the first step in the creation of new drugs, and takes place in academic institutions, biotechnology companies, and large pharmaceutical corporations. Notwithstanding, drug development shows that large pharmaceutical companies decline in the productivity. They are currently facing challenges such as patent expirations, competition from generic drugs and increasingly strict regulatory rules, so classical strategies of drug discovery and development, which are based on internal resources, are changing.
On the other hand, academia has the appropriate climate for creative and innovative science, understanding the value of individual freedom, intellectual diversity, flexibility, and originality and has expertise in many disciplines. Academic institutions have traditionally been the home of research innovation and universities are constant source of innovative drug target discovery and disease knowledge. Nevertheless, scientists in academia are often not well trained in business strategies and sometimes have little access to the necessary funding for generating the proof of principle data needed to attract investment. Consequently, many good ideas lying unexploited.
Unlike traditional research-based discovery, which seeks to understand basic cellular mechanisms and apply these learning to design new therapies, translational research targets mechanisms underlying clinically relevant problems and designs therapies to address those issues directly. Therefore, translational research or translational science is leading novel integrated discovery nexuses, establishing a forum to collaborate, exchange and develop new strategies to discover best therapies.
Several aspects can be analyzed. Although clinical pharmacology could be considered pivotal in the drug discovery process by cycling information from target selection to phase IV clinical studies, I will refer specifically at this time, to preclinical research. Preclinical studies provide a key resource for justifying clinical development. Animal experiments have contributed much to our understanding of mechanisms of disease, but their value in predicting the effectiveness of treatment strategies in clinical trials has remained controversial. Animal care, adequate experimental design (including randomization, outcome measure selection, blinding, appropriate sample size, suitable use of statistics) as well as strategies for reporting study results could help preclinical pharmacologist and toxicologist to make their experimental findings more reliable.
Rethink methods and standardization of research practices was suggested by many authors, but their exact implementation can be a challenge.
Open exchange of information about successes and failures to reproduce published data, sharing best practices, present their ideas should improve scientific research and drug discovery.
Open exchange of information about successes and failures to reproduce published data, sharing best practices, present their ideas should improve scientific research and drug discovery.
It is clear that research no longer dependent on a single one researcher. Today, it involves multidisciplinary work. Knowledge from big pharma, academia and clinical practice are seeking to share their own expertise to create more efficient system for developing new therapies.
  1. Begley C and Ioannidis J. “Be Reproducibility in Science. Improving the Standard for Basic and Preclinical Research”. Circulation Research 116.1 (2015): 116-126.
  2. Dahlin J., et al. “Mitigating risk in academic preclinical drug discovery”. Nature Reviews 14.4 (2015): 279-294.
  3. Drews J. “Drug Discovery: A Historical Perspective”. Science 287.5460 (2000): 1960-1964.
  4. Fishburn S. “Translational research: the changing landscape of drug discovery”. Drug Discovery Today 18 (9-10) (2013): 487-494.
  5. Frearson J and Wyatt P. “Drug discovery in Academia-the third way?” Expert Opinion Drug Discovery 1.10 (2010): 909-919.
  6. Loregian A and Palú G. “How academic labs can approach the drug discovery process as a way to synergize with big pharma”. Trends in Microbiology 21.6 (2013): 261-264.
  7. Steckler T., et al. “The preclinical data forum network: a new ECPN initiative to improve data quality and robustness for (preclinical) neuroscience”. European Neuropsychopharmacology 25.10 (2015): 1803-1807.
  8. Van der Worp H., et al. “Can Animal Models of Disease Reliably Inform Human Studies?” PLoS Med 7.3 (2010): e1000245.
Copyright: © 2016 Susana Gorzalczany. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for October Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the November issue of respective journals. Submissions are accepted on/before October 07, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk